Mylan Launches Generic Precedex

Mylan Launches Generic Precedex
Mylan Launches Generic Precedex

Mylan announced it has received final approval for its Abbreviated New Drug Application (ANDA) for Dexmedetomidine HCl Injection, the generic version of Hospira's Precedex.

Dexmedetomidine HCl, a selective alpha2-adrenergic agonist, is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting, and for the sedation of non-intubated patients prior to and/or during surgical and other procedures.

RELATED: Many Anesthesiologists Fail to Wash Hands, Study Finds

Dexmedetomidine HCl Injection is available as a 100mcg/mL strength packaged in 200mcg/2mL single-dose vials. Mylan has launched this product.

For more information call (800) RX-MYLAN or visit Mylan.com.